GPT and liver cancer: Nine studies investigated liver cancer incidence with varying GGT measurements [12, 13, 38, 44, 47, 48, 56, 57, 59], including one dose–response study that resulted in an HR of 2.4 (95% CI 2.19–2.65) if adjusted for high ALT, AST, ALP, BS, and TG [38].